Denyes Nancy
- SEC CIK
- 0001640869
In the past year, 1 open-market sale filing worth $1.10K and no purchases.
Current role at each company
- ATYR aTYR PHARMA INCGeneral Counselas of Feb 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.10K
- 1 filing
- Net
- −$1.10K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Denyes Nancy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 (view filing) | Feb 4 | Same day | Denyes NancyGeneral Counsel | SSale | −1.12K | $0.98 | −$1.10K | −3.3%33.1K after | |
| Feb 4, 2025 (view filing) | Feb 4 | Same day | Denyes NancyGeneral Counsel | SSale | −899 | $3.78 | −$3.40K | −3.3%26.6K after | |
| Jun 6, 2024 (view filing) | Jun 5 | 1 day | Denyes NancyGeneral Counsel | PPurchase | +5.00K | $1.86 | +$9.30K | +29.0%22.3K after |